The role involves delivering strategic clinical development planning for the ARGX-119 asset across congenital myasthenic syndromes, ALS, and spinal muscular atrophy programs.
Base: $296,000.00 - $407,000.00 USD; Bonus/Equity: Eligible for short-term and long-term incentive programs; Benefits: Comprehensive package including retirement savings and health benefits
Must-have
Nice-to-have
Not specified